<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Buscham TJ</submitter><funding>Deutsche Forschungsgemeinschaft</funding><funding>European Research Council</funding><funding>Wellcome Trust</funding><pagination>e75523</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8916772</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>11</volume><pubmed_abstract>Oligodendrocytes facilitate rapid impulse propagation along the axons they myelinate and support their long-term integrity. However, the functional relevance of many myelin proteins has remained unknown. Here, we find that expression of the tetraspan-transmembrane protein CMTM5 (chemokine-like factor-like MARVEL-transmembrane domain containing protein 5) is highly enriched in oligodendrocytes and central nervous system (CNS) myelin. Genetic disruption of the &lt;i>Cmtm5&lt;/i> gene in oligodendrocytes of mice does not impair the development or ultrastructure of CNS myelin. However, oligodendroglial &lt;i>Cmtm5&lt;/i> deficiency causes an early-onset progressive axonopathy, which we also observe in global and tamoxifen-induced oligodendroglial &lt;i>Cmtm5&lt;/i> mutants. Presence of the &lt;i>Wld&lt;sup>S&lt;/sup>&lt;/i> mutation ameliorates the axonopathy, implying a Wallerian degeneration-like pathomechanism. These results indicate that CMTM5 is involved in the function of oligodendrocytes to maintain axonal integrity rather than myelin biogenesis.</pubmed_abstract><journal>eLife</journal><pubmed_title>Progressive axonopathy when oligodendrocytes lack the myelin protein CMTM5.</pubmed_title><pmcid>PMC8916772</pmcid><funding_grant_id>Advanced Grant MyeliNano</funding_grant_id><funding_grant_id>WE 2720/2-2</funding_grant_id><funding_grant_id>WE 2720/4-1</funding_grant_id><funding_grant_id>WE 2720/5-1</funding_grant_id><pubmed_authors>Steyer AM</pubmed_authors><pubmed_authors>Boretius S</pubmed_authors><pubmed_authors>Jahn O</pubmed_authors><pubmed_authors>Buscham TJ</pubmed_authors><pubmed_authors>Strenzke N</pubmed_authors><pubmed_authors>Siems SB</pubmed_authors><pubmed_authors>Dardawal R</pubmed_authors><pubmed_authors>Sun T</pubmed_authors><pubmed_authors>Nave KA</pubmed_authors><pubmed_authors>Eichel-Vogel MA</pubmed_authors><pubmed_authors>Memhave TR</pubmed_authors><pubmed_authors>Werner HB</pubmed_authors><pubmed_authors>Muller C</pubmed_authors><pubmed_authors>Mobius W</pubmed_authors><pubmed_authors>Ruhwedel T</pubmed_authors><pubmed_authors>Meschkat M</pubmed_authors><pubmed_authors>Kramer-Albers EM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Progressive axonopathy when oligodendrocytes lack the myelin protein CMTM5.</name><description>Oligodendrocytes facilitate rapid impulse propagation along the axons they myelinate and support their long-term integrity. However, the functional relevance of many myelin proteins has remained unknown. Here, we find that expression of the tetraspan-transmembrane protein CMTM5 (chemokine-like factor-like MARVEL-transmembrane domain containing protein 5) is highly enriched in oligodendrocytes and central nervous system (CNS) myelin. Genetic disruption of the &lt;i>Cmtm5&lt;/i> gene in oligodendrocytes of mice does not impair the development or ultrastructure of CNS myelin. However, oligodendroglial &lt;i>Cmtm5&lt;/i> deficiency causes an early-onset progressive axonopathy, which we also observe in global and tamoxifen-induced oligodendroglial &lt;i>Cmtm5&lt;/i> mutants. Presence of the &lt;i>Wld&lt;sup>S&lt;/sup>&lt;/i> mutation ameliorates the axonopathy, implying a Wallerian degeneration-like pathomechanism. These results indicate that CMTM5 is involved in the function of oligodendrocytes to maintain axonal integrity rather than myelin biogenesis.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2026-05-31T05:00:23.451Z</modification><creation>2026-04-08T08:10:10.803Z</creation></dates><accession>S-EPMC8916772</accession><cross_references><pubmed>35274615</pubmed><doi>10.7554/eLife.75523</doi></cross_references></HashMap>